World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
138
Citations
87622
World Ranking
1804
National Ranking
65

Overview

Robert A. Hegele is affiliated with the University of Western Ontario in Canada and has a broad research portfolio within the fields of Medicine and Biochemistry, Genetics and Molecular Biology.

The scientist's work extends into several subfields, including Surgery, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Cancer Research, and Molecular Biology. Their research encompasses a range of topics such as Lipoproteins and Cardiovascular Health, Lipid metabolism and disorders, Diabetes, Cardiovascular Risks, and Lipoproteins, as well as Cancer, Lipids, and Metabolism. Additional topics include Health Systems, Economic Evaluations, Quality of Life, Genetic Associations and Epidemiology, and Peroxisome Proliferator-Activated Receptors.

They have contributed to scholarly literature in numerous frequently used publication venues. These include:

  • Journal of Clinical Lipidology
  • Canadian Journal of Cardiology
  • Arteriosclerosis Thrombosis and Vascular Biology
  • Atherosclerosis
  • Current Opinion in Lipidology

The scientist has coauthored extensively with several researchers, notably Daniel Gaudet, Liam R. Brunham, Adam D. McIntyre, Alexis Baass, and Jacques Genest. These collaborations reflect long-term engagement within their scientific community.

Significant recent publications demonstrate their focus areas. Key papers include:

  • "Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel," 2020, European Heart Journal
  • "2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults," 2021, Canadian Journal of Cardiology
  • "Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society," 2021, European Heart Journal
  • "Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children," 2020, Canadian Journal of Cardiology
  • "Improving reporting standards for polygenic scores in risk prediction studies," 2021, Nature

Best Publications

  • Biological, clinical and population relevance of 95 loci for blood lipids

    Tanya M. Teslovich;Kiran Musunuru;Albert V. Smith;Andrew C. Edmondson

  • Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

    Brian A Ference;Henry N Ginsberg;Ian T. Graham;Kausik K Ray

  • Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

    Borge G. Nordestgaard;M. John Chapman;Steve E. Humphries;Henry N. Ginsberg

  • Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

    Erik S. Stroes;Paul D. Thompson;Alberto Corsini;Georgirene D. Vladutiu

  • Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

    Jan Borén;M. John Chapman;M. John Chapman;Ronald M. Krauss;Chris J. Packard

  • Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)

    Sonia S Anand;Salim Yusuf;Vladmir Vuksan;Sudarshan Devanesen

  • 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult

    Todd J. Anderson;Jean Grégoire;Glen J. Pearson;Arden R. Barry

  • Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

    Marina Cuchel;Eric Bruckert;Henry N. Ginsberg;Frederick J. Raal

  • 2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult

    Todd J. Anderson;Jean Grégoire;Robert A. Hegele;Patrick Couture

  • 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations

    Jacques Genest;Ruth McPherson;Jiri Frohlich;Todd Anderson

  • Familial Hypercholesterolaemia in Children and Adolescents: Gaining Decades of Life by Optimizing Detection and Treatment

    Albert Wiegman;Samuel S. Gidding;Gerald F Watts;M John Chapman

  • Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study.

    Marina Cuchel;Emma A. Meagher;Hendrik Du Toit Theron;Dirk J. Blom;Dirk J. Blom

  • Hypertriglyceridemia: its etiology, effects and treatment

    George Yuan;Khalid Z. Al-Shali;Robert A. Hegele

  • Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy

    Henian Cao;Robert A. Hegele

  • Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction

    Ron Do;Ron Do;Nathan O. Stitziel;Hong Hee Won;Hong Hee Won;Anders Berg Jørgensen

  • Homozigot ailevi hiperkolesterolemi: klinisyenlerin tanıyı ve klinik yönetimi geliştirmelerine yönelik yeni anlayışlar ve rehberlik. Avrupa Ateroskleroz Derneği’nin Ailevi Hiperkolesterolemi Üzerine Uzlaşı Paneli yazılı görüşü

    Marina Cuchel;Eric Bruckert;Henry N. Ginsberg;Frederick J. Raal

  • Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins.

    Michael I. Mackness;Bharti Mackness;Paul N. Durrington;Philip W. Connelly

  • Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics

    Roger R. Williams;Roger R. Williams;Roger R. Williams;Steven C. Hunt;Steven C. Hunt;Steven C. Hunt;M.Catherine Schumacher;M.Catherine Schumacher;M.Catherine Schumacher;Robert A. Hegele;Robert A. Hegele;Robert A. Hegele

  • Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children

    Kara A. Nerenberg;Kelly B. Zarnke;Alexander A. Leung;Kaberi Dasgupta

  • Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE).

    Anand Ss;Yusuf S;Vuksan;Devanesen S

Frequent Co-Authors

Anthony J.G. Hanley
Anthony J.G. Hanley University of Toronto
Stewart B. Harris
Stewart B. Harris University of Western Ontario
Bernard Zinman
Bernard Zinman University of Toronto
Philip W. Connelly
Philip W. Connelly University of Toronto
Daniel J. Rader
Daniel J. Rader University of Pennsylvania
Murray W. Huff
Murray W. Huff University of Western Ontario
Sonia S. Anand
Sonia S. Anand McMaster University
Salim Yusuf
Salim Yusuf McMaster University
Daniel Gaudet
Daniel Gaudet University of Montreal
J. David Spence
J. David Spence University of Western Ontario

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in healthcare can help you advance your career without following a traditional medical school route. Many students consider online degrees in healthcare due to their flexibility and accessibility, especially if balancing work and study.

For those seeking recognized programs, it’s important to know which online healthcare degree programs are recognized for their accreditation by cahme? Accreditation ensures your qualification meets industry standards and increases your employability in competitive healthcare fields.

Nursing professionals who want to build on their credentials might look at rn to bsn online no clinicals accredited programs. These programs allow RNs to complete their bachelor’s degree fully online, streamlining the process without requiring in-person clinicals.

For advanced practice, consider the flexibility of online doctoral options. Dnp online programs are designed for working nurses pursuing leadership roles. There are also online dnp programs without dissertation, allowing experienced nurses to achieve the highest clinical degree without the traditional research-heavy approach.

Best Scientists Citing Robert A. Hegele

Trending Scientists

Recently Published Articles